Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus

Aims. To conduct an analysis of modern antihyperglycemic prescription patterns in type 2 diabetes mellitus (T2DM). Materials and methods. Russian DM State registry was studied. Results. We obtained absolute and comparative data on use of insulin analogues, dipeptidyl peptidase-4 (DPP-4) inhibitor...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Yury Ivanovich Suntsov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2012
Materias:	diabetes mellitus type 2 insulin analogues dpp-4 inhibitors glp-1 agonists Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/dcc60c358f43471d88cbed7d0e3e67d5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:dcc60c358f43471d88cbed7d0e3e67d5
record_format	dspace
spelling	oai:doaj.org-article:dcc60c358f43471d88cbed7d0e3e67d52021-11-14T09:00:17ZModern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus2072-03512072-037810.14341/2072-0351-5971https://doaj.org/article/dcc60c358f43471d88cbed7d0e3e67d52012-03-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5971https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aims. To conduct an analysis of modern antihyperglycemic prescription patterns in type 2 diabetes mellitus (T2DM). Materials and methods. Russian DM State registry was studied. Results. We obtained absolute and comparative data on use of insulin analogues, dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 agonists in treatment of T2DM. Conclusion. Percentage of DPP-4 inhibitors and GLP-1 analogues in T2DM treatment patterns remains nominal and does not exceed0.2%, which is significantly lower than in the majority of other countries. Insulin analogues are prescribed considerably more frequentlyand currently appear to be the most promising agents for treatment of T2DM.Yury Ivanovich SuntsovEndocrinology Research Centrearticlediabetes mellitus type 2insulin analoguesdpp-4 inhibitorsglp-1 agonistsNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 15, Iss 1, Pp 6-9 (2012)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus type 2 insulin analogues dpp-4 inhibitors glp-1 agonists Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus type 2 insulin analogues dpp-4 inhibitors glp-1 agonists Nutritional diseases. Deficiency diseases RC620-627 Yury Ivanovich Suntsov Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
description	Aims. To conduct an analysis of modern antihyperglycemic prescription patterns in type 2 diabetes mellitus (T2DM). Materials and methods. Russian DM State registry was studied. Results. We obtained absolute and comparative data on use of insulin analogues, dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 agonists in treatment of T2DM. Conclusion. Percentage of DPP-4 inhibitors and GLP-1 analogues in T2DM treatment patterns remains nominal and does not exceed0.2%, which is significantly lower than in the majority of other countries. Insulin analogues are prescribed considerably more frequentlyand currently appear to be the most promising agents for treatment of T2DM.
format	article
author	Yury Ivanovich Suntsov
author_facet	Yury Ivanovich Suntsov
author_sort	Yury Ivanovich Suntsov
title	Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
title_short	Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
title_full	Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
title_fullStr	Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
title_full_unstemmed	Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
title_sort	modern antihyperglycemic agents prescribed in russia for type 2 diabetes mellitus
publisher	Endocrinology Research Centre
publishDate	2012
url	https://doaj.org/article/dcc60c358f43471d88cbed7d0e3e67d5
work_keys_str_mv	AT yuryivanovichsuntsov modernantihyperglycemicagentsprescribedinrussiafortype2diabetesmellitus
_version_	1718429617614749696

Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus

Ejemplares similares